CEP905132 Supplemental material2 - Supplemental material for Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

Autor:	Messoud Ashina, Saper, Joel, Cady, Roger, Schaeffler, Barbara A, Biondi, David M, Hirman, Joe, Pederson, Susan, Allan, Brent, Smith, Jeff
Rok vydání:	2020
Předmět:	FOS: Psychology FOS: Clinical medicine 170199 Psychology not elsewhere classified 110319 Psychiatry (incl. Psychotherapy) 110306 Endocrinology 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 110904 Neurology and Neuromuscular Diseases Neuroscience
DOI:	10.25384/sage.11877231.v1
Popis:	Supplemental material, CEP905132 Supplemental material2 for Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1) by Messoud Ashina, Joel Saper, Roger Cady, Barbara A Schaeffler, David M Biondi, Joe Hirman, Susan Pederson, Brent Allan and Jeff Smith in Cephalalgia
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb16a52a6dba2cc0e6ced64a07f8a8f Zobrazit plný text záznamu